» Articles » PMID: 12076929

Breast Lesions Detected on MR Imaging: Features and Positive Predictive Value

Overview
Specialties Oncology
Radiology
Date 2002 Jun 22
PMID 12076929
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to analyze features of breast lesions detected on MR imaging that had subsequent biopsy and to determine the positive predictive value (PPV) of these features.

Materials And Methods: Retrospective review was performed of 100 consecutive solitary MR imaging-detected breast lesions that had MR imaging-guided needle localization and surgical excision. We described lesions, using terms found in a proposed breast MR imaging lexicon. Histologic findings were reviewed.

Results: Carcinoma was identified in 25 lesions (25%), including ductal carcinoma in situ (DCIS) in 13 (52%) and infiltrating carcinoma in 12 (48%). Carcinoma was found in 15 (25%) of 60 masses versus 10 (25%) of 40 nonmass lesions; most malignant masses (73%) were infiltrating carcinoma, whereas most malignant nonmass lesions (90%) were DCIS. The features with the highest PPV were spiculated margin (80% carcinoma), rim enhancement (40% carcinoma), and irregular shape (32% carcinoma) for mass lesions and segmental (67% carcinoma) or clumped linear and ductal enhancement (31% carcinoma) for nonmass lesions. Visually assessed kinetic patterns were not significant predictors of carcinoma, but washout was present in 70% of infiltrating carcinomas versus 9% of DCIS lesions (p < 0.01). Carcinoma was present in 17 (19%) of 88 lesions classified as suspicious versus eight (67%) of 12 lesions classified as highly suggestive of malignancy (p = 0.001).

Conclusion: Among MR imaging-detected breast lesions referred for biopsy, carcinoma was found in 25%, of which half were DCIS. Features with the highest PPV were spiculated margin, rim enhancement, and irregular shape for mass lesions and segmental or clumped linear and ductal enhancement for nonmass lesions. Final assessment categories were significant predictors of carcinoma.

Citing Articles

Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapy.

Saccenti L, Varble N, Borde T, Mikhail A, Kassin M, Levy E Radiol Med. 2024; 130(2):226-234.

PMID: 39656418 PMC: 11870906. DOI: 10.1007/s11547-024-01937-1.


A risk prediction stratification for non-mass breast lesions, combining clinical characteristics and imaging features on ultrasound, mammography, and MRI.

Xie Y, Zhang X Front Oncol. 2024; 14:1337265.

PMID: 39484042 PMC: 11524993. DOI: 10.3389/fonc.2024.1337265.


The Role of MRI in Breast Cancer and Breast Conservation Therapy.

Washington I, Palm R, White J, Rosenberg S, Ataya D Cancers (Basel). 2024; 16(11).

PMID: 38893241 PMC: 11171236. DOI: 10.3390/cancers16112122.


Idiopathic Granulomatous Mastitis or Breast Cancer? A Comparative MRI Study in Patients Presenting with Non-Mass Enhancement.

Boy F, Icten G, Kayadibi Y, Tasdelen I, Alver D Diagnostics (Basel). 2023; 13(8).

PMID: 37189576 PMC: 10137757. DOI: 10.3390/diagnostics13081475.


Missed and Detected Incidental Breast Cancers on Contrast Enhanced Chest CT: Detection Rates and CT Features.

Park J, Kim C, Cha Y, Chung M Diagnostics (Basel). 2023; 13(9).

PMID: 37174913 PMC: 10177537. DOI: 10.3390/diagnostics13091522.